The year ahead is shaping up as a good one for global equities. And the signals that we were looking for to see outperformance of ex-US equities versus US equities have started to line up.
In our latest Quarterly, our stance on both developed and emerging equity markets was neutral. Investors were playing a pinball game, bouncing off President Trump’s tweets and the occasional news on monetary policy. At that time, we didn’t know whether we were going to have a China-US trade deal anytime soon and earnings momentum across all the major equity markets had meaningfully weakened.
What has changed over the last three months, that tilts the needle toward more bullishness and makes us feel more sanguine about ex-US equities? Well, we have more clarity now. Global macro is proving to be more resilient than we expected, with some signs of bottoming out. More importantly for equity markets, the deterioration in earnings momentum seems to have halted.
Last but not least, the pivotal trade deal between China and the US is moving in the right direction. The two countries have just signed their Phase I agreement. The agreement is far from comprehensive and has kept in place most of the tariffs that were imposed thus far. That said, it offers hope that further escalation in the tariff war is now off the table.
Reflecting all of the above, our portfolio management teams have become more optimistic on their respective equity markets and have upgraded the conclusions of their five-factor frameworks from neutral to positive. This is the time to rerate the underdogs, as long as fundamentals continue to improve, starting with emerging markets.
This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.
Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.
The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).
The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.